Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05733520 · ClinicalTrials.gov registry record · NA
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
A NA study of Alzheimer Disease and Caregiver Burden, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 2
- Study locations
NCT05733520: Recruiting NA study of Alzheimer Disease and Caregiver Burden, sponsored by Indiana University.
NCT05733520 is a NA study of Alzheimer Disease and Caregiver Burden that is actively recruiting participants, run by Indiana University. The registered enrollment target is 184 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05733520, a NA study of Alzheimer Disease and Caregiver Burden, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 39 months, the trial will enroll 184 caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.
Primary Outcome
The burden experienced by caregivers caused by their caregiving responsibilities measured by the Neuropsychiatric Inventory (NPI) caregiver distress sub-score. The distress score is calculated by adding the distress score for each of the 12 items of the NPI. A score of 0 would indicate that the BPSD cause no distress while a score of 60 would indicate that each symptom causes severe distress for the caregiver.
Conditions Studied
Interventions
- BEHAVIORAL Brain CareNotes
- BEHAVIORAL Dementia Guide Expert
Study Locations (2)
Indiana
- IU Health - Indianapolis
- Community Health Network - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
What NCT05733520 shows while recruiting
NCT05733520 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Brain CareNotes is the first listed.
NCT05733520 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05733520 about?
NCT05733520 is a clinical study titled "I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms". This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 3...
What is the current status of trial NCT05733520?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2023-05-30. Estimated completion is 2027-07-30.
What conditions does trial NCT05733520 study?
This clinical trial studies the following conditions: Alzheimer Disease, Caregiver Burden.
What interventions are being tested in trial NCT05733520?
The interventions under investigation include: Brain CareNotes (BEHAVIORAL), Dementia Guide Expert (BEHAVIORAL).
Who is sponsoring clinical trial NCT05733520?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05733520 being conducted?
This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimer Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05733520's enrollment target sits among peer trials
184 115th of 306 higher than 192 of 306 other Alzheimer Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain Outcomes With Lifestyle Change in Down Syndrome
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
-
Connect-Home: Alzheimer's Disease and Related Dementias
RECRUITING · NA
-
Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
RECRUITING · NA
-
Low-Intensity Focused Ultrasound (LIFU) Neuromodulation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI